[go: up one dir, main page]

DK21184D0 - PROCEDURE FOR MANUFACTURING HUMAN Tissue PLASMINOGEN ACTIVATOR (TPA) IN HOST CELLS, EXPRESSION VECTOR FOR TPA AND A DHFR PROTEIN, CELL TRANSFORMED WITH THE VECTOR, AND PROCEDURES OF PRODUCT FOR PROCESS - Google Patents

PROCEDURE FOR MANUFACTURING HUMAN Tissue PLASMINOGEN ACTIVATOR (TPA) IN HOST CELLS, EXPRESSION VECTOR FOR TPA AND A DHFR PROTEIN, CELL TRANSFORMED WITH THE VECTOR, AND PROCEDURES OF PRODUCT FOR PROCESS

Info

Publication number
DK21184D0
DK21184D0 DK0211/84A DK21184A DK21184D0 DK 21184 D0 DK21184 D0 DK 21184D0 DK 0211/84 A DK0211/84 A DK 0211/84A DK 21184 A DK21184 A DK 21184A DK 21184 D0 DK21184 D0 DK 21184D0
Authority
DK
Denmark
Prior art keywords
tpa
vector
host cells
plasminogen activator
tissue plasminogen
Prior art date
Application number
DK0211/84A
Other languages
Danish (da)
Other versions
DK21184A (en
DK174081B1 (en
Inventor
Arthur David Levinson
Christian Clinton Simonsen
Elizabeth Mcleod Ylverton
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK21184D0 publication Critical patent/DK21184D0/en
Publication of DK21184A publication Critical patent/DK21184A/en
Application granted granted Critical
Publication of DK174081B1 publication Critical patent/DK174081B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Electrotherapy Devices (AREA)

Abstract

A method and vectors for producing tissue plasminogen activator (tPA) in eukaryotic host cells is disclosed. Enhanced levels of tPA production are obtained by co-amplification of the tPA gene through treatment with methotrexate of cultures transformed with expression vectors coding additionally for mutant or wild type DHFR.
DK198400211A 1983-01-19 1984-01-18 Method for producing human tissue plasminogen activator (tPA) in host cells, expression vectors for tPA and a DHFR protein, recombinant cells transformed with the vector, method for amplifying the DNA sequence, ... DK174081B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45915383A 1983-01-19 1983-01-19
US45915383 1983-01-19

Publications (3)

Publication Number Publication Date
DK21184D0 true DK21184D0 (en) 1984-01-18
DK21184A DK21184A (en) 1984-08-24
DK174081B1 DK174081B1 (en) 2002-05-27

Family

ID=23823628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198400211A DK174081B1 (en) 1983-01-19 1984-01-18 Method for producing human tissue plasminogen activator (tPA) in host cells, expression vectors for tPA and a DHFR protein, recombinant cells transformed with the vector, method for amplifying the DNA sequence, ...

Country Status (12)

Country Link
EP (1) EP0117059B1 (en)
JP (1) JPS59183693A (en)
KR (1) KR840007255A (en)
AT (1) ATE59410T1 (en)
AU (1) AU572108B2 (en)
CA (1) CA1271149A (en)
DE (1) DE3483839D1 (en)
DK (1) DK174081B1 (en)
ES (1) ES529023A0 (en)
IE (1) IE56716B1 (en)
MY (1) MY101958A (en)
ZA (1) ZA84375B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2353384A (en) * 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4713339A (en) * 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
KR850004274A (en) * 1983-12-13 1985-07-11 원본미기재 Method for preparing erythropoietin
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
GB8415186D0 (en) * 1984-06-14 1984-07-18 Ciba Geigy Ag Polypeptides
EP0174835A1 (en) * 1984-09-11 1986-03-19 The Upjohn Company Human tissue plasminogen activator and recombinant DNA compounds
EP0178105B1 (en) * 1984-10-01 1997-04-02 Genzyme Corporation Recombinant DNA techniques and the products thereof
PT82326B (en) * 1985-04-04 1988-10-14 Beecham Group Plc METHOD FOR THE PREPARATION OF FIBRINOLITICALLY ACTIVE TISSULAR TYPE PLASMINOGEN ACTIVATOR
US5672502A (en) * 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
AU593264B2 (en) * 1985-07-10 1990-02-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor
NZ217331A (en) * 1985-08-26 1989-05-29 Lilly Co Eli Tissue plasminogen activator derivatives and genetically engineered product
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
JPH0714341B2 (en) * 1985-11-20 1995-02-22 鐘淵化学工業株式会社 Method for obtaining high-producing strains of protein
US4751084A (en) * 1986-02-26 1988-06-14 Monsanto Company Tissue plasminogen activator from normal human colon cells
US4927630A (en) * 1986-02-26 1990-05-22 Monsanto Company Tissue plasminogen activator from normal human colon cells
US4851517A (en) * 1986-02-26 1989-07-25 Monsanto Company Tissue plasminogen activator oligosaccharide from normal human colon cells
US5132214A (en) * 1986-04-09 1992-07-21 Monsanto Company Large scale production of plasminogen activator from normal human colon cells
CA1297434C (en) * 1986-04-14 1992-03-17 Kenji Murakami Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
JP2585532B2 (en) * 1986-05-10 1997-02-26 三井東圧化学株式会社 Animal cell transformant, method for obtaining the same, and method for producing t-PA using the transformant
JPS62265992A (en) * 1986-05-12 1987-11-18 Ajinomoto Co Inc Production of valuable substance using human cell
IL82746A (en) * 1986-06-06 1994-10-07 Genentech Inc Process for producing biologically active tissue-type plasminogen activator
JPS63105675A (en) * 1986-10-23 1988-05-10 Green Cross Corp:The Production of human urokinase
PT86162B (en) * 1986-11-21 1990-11-20 Smithkline Beecham Corp RECOMBINANT PROTEIN EXPRESSION
ZA879286B (en) 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
EP0281246A3 (en) * 1987-02-04 1989-07-12 Invitron Corporation Method to enhance amplification and expression of foreign genes
NZ219516A (en) * 1987-02-10 1991-02-26 Wellcome Found Fusion proteins of hbcag (hepatitis b virus core antigen)
US5013653A (en) 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
US5215896A (en) * 1987-03-20 1993-06-01 Creative Biomolecules, Inc. Leader sequences for the production of recombinant proteins
CA1341345C (en) * 1987-05-08 2002-03-05 Hanne Ranch Johansen Expression of foreign genes in drosophila cells
US5681713A (en) * 1987-05-08 1997-10-28 Smithkline Beecham Corporation Expression of heterologous proteins in Drosophila cells
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5017478A (en) * 1987-07-16 1991-05-21 Berlex Laboratories, Inc. Transfected cells containing plasmids having genes oriented in opposing directions and methods of using
DE3880113T2 (en) * 1987-12-21 1993-07-15 Unilever Nv NICKEL SILICONE CATALYSTS AND THEIR PREPARATION.
ATE129289T1 (en) * 1988-12-08 1995-11-15 Abbott Lab METHOD FOR INDUCIBLE GENE EXPRESSION USING A DHFR GENE.
US5968502A (en) * 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US8653249B2 (en) 2008-02-27 2014-02-18 Fuso Pharmaceutical Industries, Ltd. Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof
KR101655492B1 (en) 2008-12-22 2016-09-07 국립대학법인 홋가이도 다이가쿠 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof
KR20180010324A (en) 2009-08-11 2018-01-30 제넨테크, 인크. Production of proteins in glutamine-free cell culture media
RU2500817C1 (en) * 2012-07-19 2013-12-10 Общество с ограниченной ответственностью "Международный биотехнологический центр "Генериум" ("МБЦ "Генериум") RECOMBINANT PLASMID DNA pBK415 CODING POLYPEPTIDE OF RECOMBINANT TISSULAR ACTIVATOR OF PLASMINOGEN OF HUMAN BEING, CELL LINE Cricetulus griseus CHO 1F8-PRODUCER OF RECOMBINANT TISSULAR ACTIVATOR OF PLASMINOGEN OF HUMAN BEING, AND METHOD FOR OBTAINING AND SEPARATION OF POLYPEPTIDE HAVING ACTIVITY OF TISSULAR ACTIVATOR OF PLASMINOGEN
EP4332231A3 (en) 2014-04-29 2024-05-29 Novartis AG Novel vertebrate cells and methods for recombinantly expressing a polypeptide of interest
EP3805396B1 (en) 2018-05-24 2024-09-11 National University Corporation Hokkaido University Novel vector and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
JPS5879205A (en) * 1981-11-06 1983-05-13 Canon Inc Manufacturing method of color separation filter
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
AU2353384A (en) * 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
JPS61185427A (en) * 1985-02-13 1986-08-19 Toyoda Gosei Co Ltd Injection apparatus
JPS6423654A (en) * 1987-07-17 1989-01-26 Fujitsu Ltd Pre-emphasis circuit

Also Published As

Publication number Publication date
MY101958A (en) 1992-02-15
CA1271149A (en) 1990-07-03
IE56716B1 (en) 1991-11-20
ES8507610A1 (en) 1985-10-01
ES529023A0 (en) 1985-10-01
IE840097L (en) 1984-07-19
AU572108B2 (en) 1988-05-05
AU2353484A (en) 1984-07-26
DK21184A (en) 1984-08-24
DE3483839D1 (en) 1991-02-07
JPS59183693A (en) 1984-10-18
EP0117059A3 (en) 1986-03-05
EP0117059B1 (en) 1990-12-27
EP0117059A2 (en) 1984-08-29
ZA84375B (en) 1985-02-27
KR840007255A (en) 1984-12-06
DK174081B1 (en) 2002-05-27
ATE59410T1 (en) 1991-01-15

Similar Documents

Publication Publication Date Title
DK21184D0 (en) PROCEDURE FOR MANUFACTURING HUMAN Tissue PLASMINOGEN ACTIVATOR (TPA) IN HOST CELLS, EXPRESSION VECTOR FOR TPA AND A DHFR PROTEIN, CELL TRANSFORMED WITH THE VECTOR, AND PROCEDURES OF PRODUCT FOR PROCESS
NO871816D0 (en) SUPEROXIDE DISMUTASE AND PROCEDURE FOR ITS MANUFACTURING
GB2191493B (en) Process for producing biologically active plasminogen activator
ES2093642T3 (en) CHO CELLS THAT PRODUCE ENZYMATICALLY ACTIVE RE-COMBINATING GLUCO-CEREBROSIDASE.
IL80960A0 (en) Process for improving the expression of eukaryotic proteins
NO910719D0 (en) VECTORS AND COMPOUNDS FOR EXPRESSION OF HUMANT PROTEIN C. GYCOSYLATION MUTANTS
GB2181741B (en) Enhancement of plasminogen activator production using heparin or low molecular weight heparin and an endothelial growth factor
UY25097A1 (en) PROCESS FOR THE PRODUCTION OF HEPARIN
DE69328992D1 (en) Human antithrombin III mutants
FI98219B (en) Process for producing a urokinase-type plasminogen activator
NO175872C (en) Plasmid vector, method for producing peptides and myeloma cell
Cini et al. Molecular basis of the isozymes of bovine glucose-6-phosphate isomerase
NZ298801A (en) Thrombolytic agent from Staphlococcus aureus
EP0227102A3 (en) Cell line established from human normal uterine muscle, method for producing plasminogen activator using the cell line, and plasminogen activator
FI894657A0 (en) A method for producing a human tissue-type plasminogen activator
JPS6427472A (en) Production of human tissue plasminogen activator and cell strain using therein
Levinson et al. Human TPA production using vectors coding for DHFR protein
JPS5794290A (en) Method for producing interferon

Legal Events

Date Code Title Description
PUP Patent expired